Author:
Brothers Thomas D.,Leaman Malcolm,Bonn Matthew,Lewer Dan,Atkinson Jacqueline,Fraser John,Gillis Amy,Gniewek Michael,Hawker Leisha,Hayman Heather,Jorna Peter,Martell David,O’Donnell Tiffany,Rivers-Bowerman Helen,Genge Leah
Funder
Canadian Institutes of Health Research
National Institutes of Health
Subject
Pharmacology (medical),Psychiatry and Mental health,Pharmacology,Toxicology
Reference63 articles.
1. Addressing the syndemic of HIV, Hepatitis C, overdose, and COVID-19 among people who use drugs: the potential roles for decriminalization and safe supply;Bonn;J. Stud. Alcohol Drugs,2020
2. Measuring the burden of opioid-related mortality in Ontario, Canada, during the COVID-19 pandemic;Gomes;JAMA Netw. Open,2021
3. Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic;Dunlop;Harm Reduct. J.,2020
4. Conceptualizing the effects of the COVID-19 pandemic on people with opioid use disorder: an application of the social ecological model;Cowan;Addict. Sci. Clin. Pr.,2021
5. Gomes, T., Murray, R., Kolla, G., Leece, P., Bansal, S., Besharah, J., et al., 2021. Changing circumstances surrounding opioid-related deaths in Ontario during the COVID-19 pandemic. Ontario Drug Policy Research Network; 2021 May [cited 2021a Sep 30]. Available from: 〈https://www.publichealthontario.ca/-/media/documents/c/2021/changing-circumstances-surrounding-opioid-related-deaths.pdf?sc_lang=en〉.
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献